Developer of genetic testing solutions for diagnosis of multiple diseases. The company's product pipeline includes trisure, a NIPT test kit for diagnosing diseases in babies before delivery, oncoGS is a test kit which is a liquid biopsy test for cancer diagnosis, and G4500 Hope for diagnosing diseases in children. The company was founded in 2018 and headquartered in Ho Chi Minh City, Vietnam. It has raised $36M in series b funding, with backing from Mekong Capital, VCAM. The company operates in the Life Sciences - Oncology, Life Sciences - Genomics, Life Sciences - Clinical Genomics space. Its offerings span Oncology - In-Vitro Diagnostic Tests - Diversified.
← All startups
Gene Solutions
Series BDeveloper of genetic testing solutions for diagnosis of multiple diseases. The company's product pipeline includes trisure, a NIPT test kit for diagnosing diseases in babies before delivery, oncoGS is a test kit which is a liquid biopsy test for cancer diagnosis, and G4500 Hope for diagnosing diseases in children. The company was founded in 2018 and headquartered in Ho Chi Minh City, Vietnam. It has raised $36M in…
About
Business model
Oncology > In-Vitro Diagnostic Tests > Diversified,
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Liquid Biopsy > DNA
Founders & team highlights
Serial Founder
Institutional investors
Mekong CapitalVCAM
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.